> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bausch Recalls Intraocular Lenses After Reports
- URL: https://www.fdaweb.com/bausch-recalls-intraocular-lenses-after-reports/
- Published: 2025-04-08T12:00:00.000Z
- Updated: 2026-09-14T14:57:14.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5158971

Bausch + Lomb has recalled its enVista intraocular lenses (IOLs) after the company received reports of complications, which it says could not immediately be explained. “The recall is in response to an increased number of reports of toxic anterior segment syndrome, and includes all lots of enVista Aspire, enVista Aspire Toric, enVista Envy and enVista Envy Toric, as well as enVista monofocal and enVista monofocal Toric IOL models,” a[ recall notice ](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bausch-lomb-announces-voluntary-recall-envista-aspiretm-envista-envytm-and-certain-envistar?utm%5Fmedium=email&utm%5Fsource=govdelivery)says.

The inflammatory reaction inside the eye, which can occur after cataract surgery, can have a variety of causes. “All enVista TASS cases reported to Bausch + Lomb to date responded quickly to treatment, and none have required removal of the lens,” the notice says, adding that reports represent only 1-2% of implanted lenses.